CAD 7.15
(1.85%)
Year | Total Debt | Total Debt Growth |
---|---|---|
2023 | 792.57 Million USD | -23.0% |
2022 | 1.02 Billion USD | 19.82% |
2021 | 859.02 Million USD | 409.51% |
2020 | 168.59 Million USD | -17.45% |
2019 | 204.24 Million USD | 871.39% |
2018 | 21.02 Million CAD | 45.39% |
2017 | 14.46 Million CAD | 165.76% |
2016 | 5.44 Million CAD | 0.0% |
Year | Total Debt | Total Debt Growth |
---|---|---|
2024 Q1 | 793.89 Million USD | 0.17% |
2024 Q2 | 800.13 Million USD | 0.79% |
2023 FY | 792.57 Million USD | -23.0% |
2023 Q2 | 967.4 Million USD | -5.48% |
2023 Q4 | 792.57 Million USD | -12.22% |
2023 Q1 | 1.02 Billion USD | -0.56% |
2023 Q3 | 902.86 Million USD | -6.67% |
2022 Q4 | 1.02 Billion USD | 9.31% |
2022 FY | 1.02 Billion USD | 19.82% |
2022 Q1 | 943.92 Million USD | 9.88% |
2022 Q2 | 960.55 Million USD | 1.76% |
2022 Q3 | 941.59 Million USD | -1.97% |
2021 Q1 | 176.73 Million USD | 4.83% |
2021 FY | 859.02 Million USD | 409.51% |
2021 Q4 | 859.02 Million USD | 152.65% |
2021 Q3 | 340 Million USD | 11.73% |
2021 Q2 | 304.31 Million USD | 72.19% |
2020 FY | 168.59 Million USD | -17.45% |
2020 Q4 | 168.59 Million USD | -36.5% |
2020 Q3 | 265.51 Million USD | 9.44% |
2020 Q2 | 242.6 Million USD | 7.78% |
2020 Q1 | 225.08 Million USD | 10.2% |
2019 Q2 | 121.13 Million USD | 125.86% |
2019 Q4 | 204.24 Million USD | 60.98% |
2019 Q3 | 126.87 Million USD | 4.74% |
2019 Q1 | 53.63 Million CAD | 155.07% |
2019 FY | 204.24 Million USD | 871.39% |
2018 Q2 | 32.09 Million CAD | 0.0% |
2018 Q4 | 21.02 Million CAD | 2.58% |
2018 FY | 21.02 Million CAD | 45.39% |
2018 Q1 | - CAD | -100.0% |
2018 Q3 | 20.49 Million CAD | -36.14% |
2017 Q4 | 14.46 Million CAD | 0.0% |
2017 Q1 | - USD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 FY | 14.46 Million CAD | 165.76% |
2016 Q4 | - CAD | 0.0% |
2016 FY | 5.44 Million CAD | 0.0% |
Name | Total Debt | Total Debt Difference |
---|---|---|
Aion Therapeutic Inc. | 826.47 Thousand CAD | -95798.218% |
Ayurcann Holdings Corp. | 709.07 Thousand CAD | -111675.831% |
Blueberries Medical Corp. | 12.8 Thousand CAD | -6189918.744% |
The BC Bud Corporation | 229.35 Thousand CAD | -345464.736% |
BioNxt Solutions Inc. | 4.89 Million CAD | -16094.215% |
CordovaCann Corp. | 6.37 Million CAD | -12323.872% |
Christina Lake Cannabis Corp. | 6.09 Million CAD | -12901.188% |
Captor Capital Corp. | 6.71 Million CAD | -11702.957% |
City View Green Holdings Inc. | 1.49 Million CAD | -52788.456% |
1CM Inc. | 6.39 Million CAD | -12295.124% |
Global Hemp Group Inc. | 3.55 Million CAD | -22184.329% |
Greenway Greenhouse Cannabis Corporation | 16.02 Million CAD | -4847.281% |
IM Cannabis Corp. | 13.78 Million CAD | -5650.762% |
Lobe Sciences Ltd. | 332.64 Thousand CAD | -238166.595% |
Maple Leaf Green World Inc. | 2.47 Million CAD | -31920.792% |
Mountain Valley MD Holdings Inc. | - CAD | -Infinity% |
Nextleaf Solutions Ltd. | 449.74 Thousand CAD | -176126.137% |
Ovation Science Inc. | 192.61 Thousand CAD | -411378.857% |
Pharmadrug Inc. | 1.76 Million CAD | -44758.534% |
Captiva Verde Wellness Corp. | 191.7 Thousand CAD | -413334.253% |
RAMM Pharma Corp. | 405.14 Thousand CAD | -195528.672% |
RIV Capital Inc. | 6.59 Million CAD | -11921.386% |
Revive Therapeutics Ltd. | 25.21 Thousand CAD | -3143023.414% |
Red White & Bloom Brands Inc. | 262.13 Million CAD | -202.356% |
SLANG Worldwide Inc. | 29.86 Million CAD | -2553.651% |
1933 Industries Inc. | 17.57 Million CAD | -4410.664% |
Red Light Holland Corp. | 811.04 Thousand CAD | -97621.834% |
Top Strike Resources Corp. | 13.29 Million CAD | -5863.515% |
Xebra Brands Ltd. | - CAD | -Infinity% |
Adastra Holdings Ltd. | 3.58 Million CAD | -22018.556% |